Pure Global

"Beckman Coulter" DxH 500 Series Hemocytolytic Agent (Unsterilized) - Taiwan Registration 3e360ba2121dc6c3657e8e245c8fd705

Access comprehensive regulatory information for "Beckman Coulter" DxH 500 Series Hemocytolytic Agent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3e360ba2121dc6c3657e8e245c8fd705 and manufactured by BIT GROUP FRANCE;; BECKMAN COULTER IRELAND INC.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3e360ba2121dc6c3657e8e245c8fd705
Registration Details
Taiwan FDA Registration: 3e360ba2121dc6c3657e8e245c8fd705
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Beckman Coulter" DxH 500 Series Hemocytolytic Agent (Unsterilized)
TW: "่ฒๅ…‹ๆ›ผๅบซ็ˆพ็‰น" DxH 500็ณปๅˆ—่ก€็ƒๆบถ่งฃๅŠ‘ (ๆœชๆป…่Œ)
Risk Class 1

Registration Details

3e360ba2121dc6c3657e8e245c8fd705

DHA09401823000

Company Information

Product Details

Limited to the classification and grading management measures for medical devices, the first level identification range of "red blood cell lytic agent (B.8540)".

B Hematology, pathology, and genetics

B.8540 ็ด…่ก€็ƒๆบถ่งฃๅŠ‘

Input;; Contract manufacturing

Dates and Status

Aug 23, 2017

Aug 23, 2027